## FIVE: Five Below, Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.27 indicates fundamental undervaluation. Quality metrics strong (ROE 17%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-1.9% MRS), overbought RSI (73).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($176.53)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Five Below, Inc. Announces Participation in the 2026 ICR Conference**
- Source: The Globe and Mail | 20251222T221022 | Neutral | Relevance: 100%
- Five Below, Inc. announced that its management will host a fireside chat at the 2026 ICR Conference in Orlando, Florida, on Monday, January 12, 2026, at 10:00 a.m. Eastern Time. The event will be webcast live, and an archived replay will be available afterward. The company also plans to release its holiday sales results on the same day, prior to the market open.

**2. Jim Cramer Says Five Below “Would Benefit Enormously If the Tariffs Get Struck Down”**
- Source: Insider Monkey | 20251221T100800 | Bullish | Relevance: 100%
- Jim Cramer highlighted that Five Below, Inc. (NASDAQ: FIVE) would significantly benefit if tariffs were removed, praising CEO Winnie Park's leadership for the company's strong multi-year growth and impressive 14% same-store sales growth. Park's strategies, including sharpening customer focus, leveraging digital channels, and creating "curtain-up moments" for seasonal merchandise, have driven sales acceleration, putting Five Below in a turnaround mode with potential for future gains for shareholders. Cramer also noted the company's ability to avoid profit hits from tariffs as a "secret sauce."

**3. Evercore ISI Boosts Five Below (NASDAQ:FIVE) Price Target to $185.00**
- Source: MarketBeat | 20251223T140958 | Somewhat-Bullish | Relevance: 100%
- Evercore ISI has increased its price target for Five Below (NASDAQ:FIVE) to $185, maintaining an "in-line" rating, while other firms like JPMorgan and Guggenheim have also raised their targets following strong Q3 earnings. The specialty retailer reported a significant beat on EPS and revenue, alongside positive FY2025 guidance, prompting multiple analyst upgrades. Despite positive analyst sentiment, there have been recent insider stock sales totaling 35,244 shares valued at approximately $6.23 million.

**4. Is Five Below (FIVE) Overvalued After Its Strong Share Price Rally This Year?**
- Source: Yahoo Finance | 20251223T101000 | Somewhat-Bearish | Relevance: 100%
- Five Below (FIVE) has seen a significant rally this year, with its stock up approximately 88% year-to-date and 20% in the past month, outperforming retail peers. Despite this strong performance, Simply Wall St's analysis suggests that the stock is currently overvalued, with a fair value of $163.14 compared to its closing price of $186.54. Operational improvements are expected to drive future growth, but tariff, labor costs, and aggressive expansion risks could impact long-term expectations.

**5. Five Below (NASDAQ:FIVE) Reaches New 1-Year High - Here's Why**
- Source: MarketBeat | 20251222T161022 | Bullish | Relevance: 100%
- Five Below (NASDAQ:FIVE) reached a new 52-week high of $185.92 during intraday trading on Monday, driven by strong Q3 2025 results that beat analyst expectations and positive guidance for Q4 and FY2025. Several analysts have upgraded the stock and raised price targets, contributing to a "Moderate Buy" consensus rating. However, recent insider selling activity has also been noted.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 21, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Evercore ISI Gr | $185 | $180 | +3% |
| 2025-12-19 | Wells Fargo | $200 | $190 | +5% |
| 2025-12-08 | Morgan Stanley | $190 | $160 | +19% |
| 2025-12-08 | Truist Securiti | $216 | $179 | +21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Evercore ISI Gr | main | In-Line |
| 2025-12-19 | Wells Fargo | main | Overweight |
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Truist Securiti | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.12M) |
| Sells | 7 ($1.99M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+1.3%)
- Blackrock Inc.: 9.1% (-5.9%)
- FMR, LLC: 4.0% (+1.7%)
- Shaw D.E. & Co., Inc: 3.8% (-28.0%)
- American Century Com: 3.4% (+21.6%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 21 raises (avg +11%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.27 suggests fair value with growth premium. Forward P/E 30.0x stretched relative to 6% growth. Analyst sentiment positive (21 raises, avg +11%). Insider selling cluster ($2.0M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $10.4B |
| Beta | 1.17 |
| 52W Range | $52.38 - $188.72 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.27 |
| Forward P/E | 30.0 |
| Current P/E | 31.9 |
| YoY Growth | 6.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 8.5% to 6.6% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 0.8% confirms short-term momentum alignment. AM_20 at 7.7% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.79), confirming momentum. RSI overbought at 73, risk of mean reversion. OFD pattern: +DLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.61% (CS: 95) | Strong |
| RSI_14 | 73.0 | Overbought |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.077x | Above |
| vs SMA50 | 1.160x | Above |
| vs SMA200 | 1.462x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $187.81
- **Stop Loss:** $176.53 (6.0% risk)
- **Target:** $210.37 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 79
- **Position Value:** $14,836.99
- **Portfolio %:** 14.84%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-03-18 (Est: $3.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.26 | $0.68 | +165.4% |
| 2025Q3 | $0.63 | $0.81 | +29.4% |
| 2025Q2 | $0.83 | $0.86 | +3.4% |
| 2025Q1 | $3.37 | $3.48 | +3.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*